2003
DOI: 10.1159/000071155
|View full text |Cite
|
Sign up to set email alerts
|

A Light in Multidrug Resistance: Photodynamic Treatment of Multidrug-Resistant Tumors

Abstract: The major drawback of cancer chemotherapy is the development of multidrug-resistant (MDR) tumor cells, which are cross-resistant to a broad range of structurally and functionally unrelated agents, making it difficult to treat these tumors. In the last decade, a number of authors have studied the effects of photodynamic therapy (PDT), a combination of visible light with photosensitizing agents, on MDR cells. The results, although still inconclusive, have raised the possibility of treating MDR tumors by PDT. Thi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0

Year Published

2003
2003
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(16 citation statements)
references
References 45 publications
(51 reference statements)
1
15
0
Order By: Relevance
“…So far, some studies have reported the potency of PDT in multidrug resistant cells 10. The photodynamic effect of Photofrin®(Lederle Laboratories, Oullins, France) was slightly lower in doxorubicin‐resistant Friend leukemia cell line than in the parental sensitive cell line, which might be due to increase in ABCB1‐mediated efflux of Photofrin® from the drug‐resistant cells 34.…”
Section: Discussionmentioning
confidence: 99%
“…So far, some studies have reported the potency of PDT in multidrug resistant cells 10. The photodynamic effect of Photofrin®(Lederle Laboratories, Oullins, France) was slightly lower in doxorubicin‐resistant Friend leukemia cell line than in the parental sensitive cell line, which might be due to increase in ABCB1‐mediated efflux of Photofrin® from the drug‐resistant cells 34.…”
Section: Discussionmentioning
confidence: 99%
“…260-263 Their results, although still inconclusive, have opened the possibility of treating multidrug-resistant tumours with PDT. 264 …”
Section: Future Trendsmentioning
confidence: 99%
“…In addition, due to its low risk, can be used in people who are elderly or frail to undergo other surgery. The main side effect is sensitization to light, which is circumvented by avoiding exposure to sunlight and interior light too intense for a period of up to 6 weeks depending on the photosensitizer 45.…”
Section: Discussionmentioning
confidence: 99%